Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK-3/CDK5/CDK2-IN-1 is an imidazole derivative compound that inhibits cdk5, cdk2, and GSK-3.it has demonstrated applications in cancer research and the study of neurodegenerative diseases [1].
Description | GSK-3/CDK5/CDK2-IN-1 is an imidazole derivative compound that inhibits cdk5, cdk2, and GSK-3.it has demonstrated applications in cancer research and the study of neurodegenerative diseases [1]. |
In vitro | GSK-3/CDK5/CDK2-IN-1 inhibits the phosphorylation of cdk5 peptide substrate phosphorylation, with an IC50 of less than about 50 μM[1]. |
Synonyms | GSK-3/CDK5/CDK2-IN-1 |
Molecular Weight | 362.433 |
Formula | C21H22N4O2 |
CAS No. | 395074-72-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (275.92 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK-3/CDK5/CDK2-IN-1 395074-72-3 GSK3/CDK5/CDK2IN1 GSK-3/CDK-5/CDK2-IN-1 GSK 3/CDK5/CDK2 IN 1 inhibitor inhibit